Literature DB >> 3457732

Alloplastic reconstruction of the temporomandibular joint.

E S Moriconi, L D Popowich, L H Guernsey.   

Abstract

The Proplast TMJ condylar implant, the glenoid fossa implant, and the TMJ interpositional implants should be singled out as having provided a new and more predictable mode of TMJ reconstruction. The use of these implants in cases of ankylosis, degenerative joint disease, orthognathic deformities, and traumatic injuries has greatly contributed to the success of these reconstructions. These implants represent the state of the art in TMJ reconstruction and increasing data from longer-term follow-up have shown a rate of success much higher than any previous implant used in the TMJ. TMJ reconstruction requires careful surgical planning, meticulous surgical technique, and intelligent perioperative care. Postoperative physical therapy is considered essential in the management of these patients. Complications related to reankylosis have been virtually eliminated, as no postoperative immobilization is required in most cases. Long-term stability of these implants, due to the ingrowth of tissue into Proplast, appears to be assured. Continued experience with the implants and close follow-up of reconstruction patients is necessary in the future to adequately assess the performance of the newer glenoid fossa and TMJ interpositional implants. Certainly, a new era in TMJ reconstruction has begun, resulting in increased benefits to the patients whom we all serve.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3457732

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  2 in total

1.  TMJ Ankylosis Management: Our Experience.

Authors:  Satyapriya Shivakotee; Col Suresh Menon; M E Sham; Veerendra Kumar; S Archana
Journal:  J Maxillofac Oral Surg       Date:  2019-09-30

2.  Evaluation of surgically retrieved temporomandibular joint alloplastic implants: pilot study.

Authors:  Joao N A R Ferreira; Ching-Chang Ko; Sandra Myers; James Swift; James R Fricton
Journal:  J Oral Maxillofac Surg       Date:  2008-06       Impact factor: 1.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.